What NJ pharmacies actually sell for, why script count and payer mix determine the multiple, and how the DEA registration transfer works.
NJ independent pharmacies are among the highest-multiple small businesses on the market — 4× to 7× SDE — because they combine recurring prescription revenue, high switching costs for patients, and significant barriers to entry (licensing, DEA registration, insurer credentialing). The multiple you achieve depends almost entirely on your monthly script count and the composition of your payer mix.
| Metric | Typical Range (NJ) |
|---|---|
| SDE multiple | 4× – 7× |
| Monthly scripts (small pharmacy) | 1,000–2,500 Rx/month |
| Monthly scripts (established) | 2,500–6,000+ Rx/month |
| Typical close timeline | 8–14 months |
| Most common buyer type | Independent operators, pharmacy chains, PE consolidators |
Ranges based on recent NJ/NY/CT market activity. Request a free valuation for a range specific to your business.
Script count is the primary value metric. Every additional 500 Rx/month represents meaningful recurring revenue. Provide 24 months of monthly fill counts, split by brand vs. generic and acute vs. maintenance. Buyers and their appraisers will analyze script trends — steady or growing counts command premiums; declining counts raise red flags.
Not all prescriptions are equal. Commercial (employer-sponsored) insurance pays the best rates. Medicare Part D pays less. Medicaid managed care pays least. A pharmacy with 60%+ commercial payer mix is worth more than one heavily dependent on Medicaid or fee-for-service Medicare. Document your payer mix breakdown.
Direct and Indirect Remuneration (DIR) fees — retroactive clawbacks from PBMs on Medicare Part D prescriptions — have dramatically reduced pharmacy profitability in recent years. Buyers will analyze DIR fee exposure carefully. Document your DIR fees for the trailing 24 months to help buyers normalize true net revenue.
A licensed NJ compounding pharmacy with established prescribers commands a significant premium. Compounding margins are substantially higher than dispensing margins, and the prescriber relationships are sticky. NJ Board of Pharmacy compound pharmacy registration must be reviewed and transferred.
Long-term care pharmacy contracts (nursing homes, assisted living facilities) provide large, predictable volume. Specialty pharmacy capabilities (oncology, HIV, MS, RA) command the highest multiples of all — specialty drugs have enormous margins and high patient retention.
NJ pharmacy permits are issued by the NJ Board of Pharmacy and must be transferred when ownership changes. The new owner must apply for a new pharmacy permit, demonstrate licensed pharmacist ownership/supervision, and pass a facility inspection. The transfer process typically takes 60–90 days.
The DEA Schedule II–V registration is the critical federal license for dispensing controlled substances. DEA registrations do not automatically transfer in an asset sale — the new owner must apply for a new registration. During the gap between closing and new DEA registration approval, controlled substances cannot be dispensed. This is a material operational issue that must be planned for carefully.
NJ Medicaid pharmacy provider enrollment does not transfer automatically. The new owner must complete re-enrollment, which can take 60–120 days. Medicaid revenue will be interrupted during this period — factor this into the transition plan and post-closing working capital.
NJ independent pharmacies typically sell for 4× to 7× SDE. High-volume pharmacies with commercial payer mix, compounding capability, or LTC contracts trade at the top of the range. Declining-count pharmacies with heavy Medicaid exposure trade lower.
DEA registrations do not automatically transfer in an asset sale. The new owner must apply for a new registration, and controlled substances cannot be dispensed during the application period. In a stock sale, the DEA registration stays with the entity — this is why many pharmacy buyers prefer stock transactions.
DIR fees are retroactive clawbacks from pharmacy benefit managers on Medicare Part D prescriptions, assessed months after the original dispensing. They have significantly reduced independent pharmacy profitability. Buyers normalize SDE to account for DIR fees. We document your DIR fee history to help buyers properly analyze true net income.
Pharmacy sales are among the most complex small business transactions — 8–14 months is typical. NJ Board of Pharmacy permit transfer, DEA registration, and insurer re-credentialing all require sequential steps that cannot be rushed.
No upfront fee. No obligation. You’ll know in 30 minutes what your business is likely to sell for in today’s NJ market.
No obligation. No upfront fee. We reply within 1 business day.